{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T06:29:11Z","timestamp":1787898551745,"version":"build-2784847793"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Cisplatin (CIS) is a platinum-based chemotherapeutic drug that is widely used to treat cancer. However, its therapeutic efficiency is limited due to its potential to provoke neurotoxicity. Sulforaphane (SF) is a natural phytochemical that demonstrated several protective activities. Iron oxide nanoparticles (Fe<jats:sub>3<\/jats:sub>O<jats:sub>4<\/jats:sub>-NPs) could be used as drug carriers. This study aimed to explore the nanotoxic influence of SF-loaded within Fe<jats:sub>3<\/jats:sub>O<jats:sub>4<\/jats:sub>-NPs (N.SF), and to compare the neuroprotective potential of both N.SF and SF against CIS-induced neurotoxicity. N.SF or SF was administrated intranasally for 5\u00a0days before and 3\u00a0days after a single dose of CIS (12\u00a0mg\/kg\/week, i.p.) on the 6<jats:sup>th<\/jats:sup>day. Neuromuscular coordination was assessed using hanging wire and tail-flick tests. Acetylcholinesterase (AChE) activities and markers of oxidative stress were measured in the brain. In addition, the brain iron (Fe) content was estimated. CIS significantly induced a significant increase in AChE activities and lipid peroxides, and a significant decrement in glutathione (GSH) and nitric oxide (NO) contents. CIS elicited impaired neuromuscular function and thermal hyperalgesia. CIS-induced brains displayed a significant reduction in Fe content. Histopathological examination of different brain regions supported the biochemical and behavioral results. Contradict, treatment of CIS-rats with either N.SF or SF significantly decreased AChE activity, mitigated oxidative stress, and ameliorated the behavioral outcome. The histopathological features supported our results. Collectively, N.SF demonstrated superior neuroprotective activities on the behavioral, biochemical, and histopathological (striatum and cerebral cortex) aspects. N.SF could be regarded as a promising \u201cpre-clinical\u201d neuroprotective agent. Furthermore, this study confirmed the safe toxicological profile of Fe<jats:sub>3<\/jats:sub>O<jats:sub>4<\/jats:sub>-NPs.<\/jats:p>","DOI":"10.1007\/s12640-022-00555-x","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T07:02:57Z","timestamp":1660546977000},"page":"1479-1498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Neuroprotective Potential of Intranasally Delivered Sulforaphane-Loaded Iron Oxide Nanoparticles Against Cisplatin-Induced Neurotoxicity"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3665-3153","authenticated-orcid":false,"given":"Ghadha","family":"Ibrahim Fouad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A. M.","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3330-6762","authenticated-orcid":false,"given":"Mostafa","family":"Mabrouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7376-7411","authenticated-orcid":false,"given":"Kawkab A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5885-2845","authenticated-orcid":false,"given":"Hanan H.","family":"Beherei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"key":"555_CR1","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3389\/fphar.2017.00370","volume":"8","author":"S Adesso","year":"2017","unstructured":"Adesso S, Magnus T, Cuzzocrea S, Campolo M et al (2017) Indoxyl sulfate affects glial function increasing oxidative stress and neuroinflammation in chronic kidney disease: interaction between astrocytes and microglia. Front Pharmacol 8:370","journal-title":"Front Pharmacol"},{"key":"555_CR2","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ejphar.2017.08.040","volume":"814","author":"N Ahmad","year":"2017","unstructured":"Ahmad N, Subhan F, Islam NU, Shahid M, Rahman FU, Sewell RD (2017) Gabapentin and its salicylaldehyde derivative alleviate allodynia and hypoalgesia in a cisplatin-induced neuropathic pain model. Eur J Pharmacol 814:302\u2013312","journal-title":"Eur J Pharmacol"},{"key":"555_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.172972","volume":"872","author":"S Akbar","year":"2020","unstructured":"Akbar S, Subhan F, Shahid M, Wadood A et al (2020) 6-Methoxyflavanone abates cisplatin-induced neuropathic pain apropos anti-inflammatory mechanisms: a behavioral and molecular simulation study. Eur J Pharmacol 872:172972","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"555_CR4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s13181-012-0239-x","volume":"9","author":"MS Al Moundhri","year":"2013","unstructured":"Al Moundhri MS, Al-Salam S, Al Mahrouqee A, Beegam S, Ali BH (2013) The effect of curcumin on oxaliplatin and cisplatin neurotoxicity in rats: some behavioral, biochemical, and histopathological studies. J Med Toxicol 9(1):25\u201333","journal-title":"J Med Toxicol"},{"key":"555_CR5","doi-asserted-by":"crossref","unstructured":"Ali BH, Ramkumar A, Madanagopal TT, Waly MI, Tageldin M et al (2014) Motor and behavioral changes in mice with cisplatin-induced acute renal failure.\u00a0Physiological Res\u00a063(1)","DOI":"10.33549\/physiolres.932585"},{"key":"555_CR6","unstructured":"American Public Health Association (APHA), American Water Works Association (AWWA), and Water Environment Federation (WEF) (2017) Standard methods for the examination of water and wastewater, 23rd edn. In: Rice EW, Baird RB, Eaton AD, Clesceri LS (eds). Washington DC"},{"issue":"1","key":"555_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.critrevonc.2011.04.012","volume":"82","author":"AA Argyriou","year":"2012","unstructured":"Argyriou AA, Bruna J, Marmiroli P, Cavaletti G (2012) Chemotherapy-induced peripheral neurotoxicity (CIPN): an update. Crit Rev Oncol Hematol 82(1):51\u201377","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"555_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.expneurol.2006.03.034","volume":"201","author":"D Avella","year":"2006","unstructured":"Avella D, Pisu MB, Roda E, Gravati M, Bernocchi G (2006) Reorganization of the rat cerebellar cortex during postnatal development following cisplatin treatment. Experim Neurol 201(1):131\u2013143","journal-title":"Experim Neurol"},{"key":"555_CR9","doi-asserted-by":"crossref","unstructured":"Benedict AL, MountneyA, Hurtado A, Bryan KE, Schnaar RL, Dinkova-Kostova AT, Talalay P (2012) Neuroprotective effects of sulforaphane after contusive spinal cord injury","DOI":"10.1089\/neu.2012.2474"},{"key":"555_CR10","first-page":"882","volume":"61","author":"E Beutler","year":"1963","unstructured":"Beutler E, Duron O, Kelly BM (1963) Improved method for the determination of blood glutathione. J Lab Clin Med 61:882\u2013888","journal-title":"J Lab Clin Med"},{"issue":"1","key":"555_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep06370","volume":"4","author":"W Boehmerle","year":"2014","unstructured":"Boehmerle W, Huehnchen P, Peruzzaro S, Balkaya M, Endres M (2014) Electrophysiological, behavioral and histological characterization of paclitaxel, cisplatin, vincristine and bortezomib-induced neuropathy in C57Bl\/6 mice. Sci Rep 4(1):1\u20139","journal-title":"Sci Rep"},{"key":"555_CR12","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.biopha.2017.07.038","volume":"93","author":"IH Borai","year":"2017","unstructured":"Borai IH, Ezz MK, Rizk MZ, Aly HF, El-Sherbiny M, Matloub AA, Fouad GI (2017) Therapeutic impact of grape leaves polyphenols on certain biochemical and neurological markers in AlCl3-induced Alzheimer\u2019s disease. Biomed Pharmacother 93:837\u2013851","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"555_CR13","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1038\/s41467-017-01837-1","volume":"8","author":"AM Breglio","year":"2017","unstructured":"Breglio AM, Rusheen AE, Shide ED, Fernandez KA, Spielbauer KK, McLachlin KM, Hall MD, Amable L, Cunningham LL (2017) Cisplatin is retained in the cochlea indefinitely following chemotherapy. Nature Commun 8(1):1654. https:\/\/doi.org\/10.1038\/s41467-017-01837-1","journal-title":"Nature Commun"},{"issue":"5","key":"555_CR14","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1039\/c8fo00018b","volume":"9","author":"A Briones-Herrera","year":"2018","unstructured":"Briones-Herrera A, Eugenio-Perez D, Reyes-Ocampo JG, Rivera-Mancia S, Pedraza-Chaverri J (2018) New highlights on the health-improving effects of sulforaphane. Food Funct 9(5):2589\u20132606. https:\/\/doi.org\/10.1039\/c8fo00018b","journal-title":"Food Funct"},{"issue":"5","key":"555_CR15","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/jat.3760","volume":"39","author":"LSP Bugata","year":"2019","unstructured":"Bugata LSP, Pitta Venkata P, Gundu AR, Mohammed Fazlur R, Reddy UA et al (2019) Acute and subacute oral toxicity of copper oxide nanoparticles in female albino Wistar rats. J App Toxicol 39(5):702\u2013716","journal-title":"J App Toxicol"},{"key":"555_CR16","doi-asserted-by":"crossref","unstructured":"Busquets M, Espargar\u00f3 A, Sabat\u00e9 R, Estelrich J (2015) Magnetic nanoparticles cross the blood-brain barrier: when physics rises to a challenge. J Nanomater 5:2231\u20132248","DOI":"10.3390\/nano5042231"},{"key":"555_CR17","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3389\/fphar.2020.00567","volume":"11","author":"C Calcabrini","year":"2020","unstructured":"Calcabrini C, Maffei F, Turrini E, Fimognari C (2020) Sulforaphane potentiates anticancer effects of doxorubicin and cisplatin and mitigates their toxic effects. Front Pharmacol 11:567","journal-title":"Front Pharmacol"},{"key":"555_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.neulet.2014.10.014","volume":"596","author":"VA Carozzi","year":"2015","unstructured":"Carozzi VA, Canta A, Chiorazzi A (2015) Chemotherapy-induced peripheral neuropathy: what do we know about mechanisms? Neurosci Lett 596:90\u2013107","journal-title":"Neurosci Lett"},{"issue":"3","key":"555_CR19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/toxics3030304","volume":"3","author":"A Chiorazzi","year":"2015","unstructured":"Chiorazzi A, Semperboni S, Marmiroli P (2015) Current view in platinum drug mechanisms of peripheral neurotoxicity. Toxics 3(3):304\u2013321","journal-title":"Toxics"},{"key":"555_CR20","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.addr.2019.01.005","volume":"138","author":"SM Dadfar","year":"2019","unstructured":"Dadfar SM, Roemhild K, Drude NI, von Stillfried S, Kn\u00fcchel R, Kiessling F, Lammers T (2019) Iron oxide nanoparticles: diagnostic, therapeutic and theranostic applications. Adv Drug Deliv Rev 138:302\u2013325. https:\/\/doi.org\/10.1016\/j.addr.2019.01.005","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"555_CR21","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/jps.21924","volume":"99","author":"SV Dhuria","year":"2010","unstructured":"Dhuria SV, Hanson LR, Frey WH II (2010) Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharmaceut Scien 99(4):1654\u20131673","journal-title":"J Pharmaceut Scien"},{"key":"555_CR22","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.ijbiomac.2021.04.045","volume":"181","author":"TM Don","year":"2021","unstructured":"Don TM, Chang WJ, Jheng PR, Huang YC, Chuang EY (2021) Curcumin-laden dual-targeting fucoidan\/chitosan nanocarriers for inhibiting brain inflammation via intranasal delivery. Int J Biol Macromol 181:835\u2013846","journal-title":"Int J Biol Macromol"},{"key":"555_CR23","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.brainresbull.2018.10.009","volume":"143","author":"F Erd\u0151","year":"2018","unstructured":"Erd\u0151 F, Bors LA, Farkas D, Bajza \u00c1, Gizurarson S (2018) Evaluation of intranasal delivery route of drug administration for brain targeting. Brain Res Bull 143:155\u2013170","journal-title":"Brain Res Bull"},{"issue":"4","key":"555_CR24","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s11064-020-03209-6","volume":"46","author":"OM Farag","year":"2021","unstructured":"Farag OM, Abd-Elsalam RM, Ogaly HA, Ali SE et al (2021) Metabolomic profiling and neuroprotective effects of purslane seeds extract against acrylamide toxicity in rat\u2019s brain. Neurochem Res 46(4):819\u2013842","journal-title":"Neurochem Res"},{"issue":"5","key":"555_CR25","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1007\/s11064-020-02996-2","volume":"45","author":"GI Fouad","year":"2020","unstructured":"Fouad GI (2020) Combination of omega 3 and coenzyme Q10 exerts neuroprotective potential against hypercholesterolemia-induced Alzheimer\u2019s-like disease in rats. Neurochem Res 45(5):1142\u20131155","journal-title":"Neurochem Res"},{"issue":"23","key":"555_CR26","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1200\/JCO.2016.66.8822","volume":"34","author":"RD Frisina","year":"2016","unstructured":"Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C et al (2016) Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer. J Clin Oncol 34(23):2712","journal-title":"J Clin Oncol"},{"issue":"1\u20133","key":"555_CR27","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.tox.2011.04.014","volume":"286","author":"L Gaona-Gaona","year":"2011","unstructured":"Gaona-Gaona L, Molina-Jij\u00f3n E, Tapia E, Zazueta C, Hern\u00e1ndez-Pando R et al (2011) Protective effect of sulforaphane pretreatment against cisplatin-induced liver and mitochondrial oxidant damage in rats. Toxicol 286(1\u20133):20\u201327","journal-title":"Toxicol"},{"key":"555_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.expneurol.2014.10.017","volume":"263","author":"PS Garry","year":"2015","unstructured":"Garry PS, Ezra M, Rowland MJ, Westbrook J, Pattinson KTS (2015) The role of the nitric oxide pathway in brain injury and its treatment-from bench to bedside. Exp Neuro 263:235\u2013243","journal-title":"Exp Neuro"},{"key":"555_CR29","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.conb.2005.10.006","volume":"15","author":"AM Graybiel","year":"2005","unstructured":"Graybiel AM (2005) The basal ganglia: learning new tricks and loving it. Curr Opin Neurobiol 15:638\u2013644. https:\/\/doi.org\/10.1016\/j.conb.2005.10.006","journal-title":"Curr Opin Neurobiol"},{"issue":"5","key":"555_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.etp.2010.11.005","volume":"64","author":"CE Guerrero-Beltr\u00e1n","year":"2012","unstructured":"Guerrero-Beltr\u00e1n CE, Calder\u00f3n-Oliver M, Pedraza-Chaverri J, Chirino YI (2012) Protective effect of sulforaphane against oxidative stress: recent advances. Experimental and Toxicol Pathol 64(5):503\u2013508","journal-title":"Experimental and Toxicol Pathol"},{"issue":"1","key":"555_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1440-1819.2012.02395.x","volume":"67","author":"M Gulec","year":"2013","unstructured":"Gulec M, Oral E, Dursun OB, Yucel A, Hacimuftuoglu A, Akcay F, Suleyman H (2013) Mirtazapine protects against cisplatin-induced oxidative stress and DNA damage in the rat brain. Psych Clin Neurosci 67(1):50\u201358","journal-title":"Psych Clin Neurosci"},{"key":"555_CR32","first-page":"953","volume":"80","author":"O Hikosaka","year":"2000","unstructured":"Hikosaka O, Takikawa Y, Kawagoe R (2000) Role of the basal ganglia in the control of purposive saccadic eye movements Physiol. Rev 80:953\u2013978","journal-title":"Rev"},{"issue":"1","key":"555_CR33","first-page":"1","volume":"8","author":"W Huang","year":"2018","unstructured":"Huang W, Tsui CP, Tang CY, Gu L (2018) Effects of Compositional Tailoring on Drug Delivery Behaviours of Silica Xerogel\/polymer Core-Shell Composite Nanoparticles Sci Rep 8(1):1\u201313","journal-title":"Effects of Compositional Tailoring on Drug Delivery Behaviours of Silica Xerogel\/polymer Core-Shell Composite Nanoparticles Sci Rep"},{"key":"555_CR34","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.ijbiomac.2020.05.115","volume":"159","author":"J Hussein","year":"2020","unstructured":"Hussein J, El-Naggar ME, Fouda MM, Morsy OM, Ajarem JS et al (2020) The efficiency of blackberry loaded AgNPs, AuNPs and Ag@ AuNPs mediated pectin in the treatment of cisplatin-induced cardiotoxicity in experimental rats. Int J Biol Macromol 159:1084\u20131093","journal-title":"Int J Biol Macromol"},{"issue":"12","key":"555_CR35","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1007\/s11064-021-03428-5","volume":"46","author":"G Ibrahim Fouad","year":"2021","unstructured":"Ibrahim Fouad G, Ahmed KA (2021) Neuroprotective potential of berberine against doxorubicin-induced toxicity in rat\u2019s brain. Neurochem Res 46(12):3247\u20133263","journal-title":"Neurochem Res"},{"issue":"4","key":"555_CR36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s002800050581","volume":"39","author":"RK Jarve","year":"1997","unstructured":"Jarve RK, Aggarwal SK (1997) Cisplatin-induced inhibition of the calcium-calmodulin complex, neuronal nitric oxide synthase activation and their role in stomach distention. Cancer Chemoth Pharmacol 39(4):341\u2013348","journal-title":"Cancer Chemoth Pharmacol"},{"issue":"12","key":"555_CR37","first-page":"2347","volume":"14","author":"A Jazwa","year":"2011","unstructured":"Jazwa A, Rojo AI, Innamorato NG, Hesse M, Fern\u00e1ndez-Ruiz J, Cuadrado A (2011) Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental Parkinsonism. ARS 14(12):2347\u20132360","journal-title":"ARS"},{"issue":"10","key":"555_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025404","volume":"6","author":"SY Jeong","year":"2011","unstructured":"Jeong SY, Crooks DR, Wilson-Ollivierre H, Ghosh MC et al (2011) Iron insufficiency compromises motor neurons and their mitochondrial function in Irp2-null mice. PLoS ONE 6(10):e25404","journal-title":"PLoS ONE"},{"key":"555_CR39","doi-asserted-by":"crossref","unstructured":"Kazak F, Akal\u0131n PP, Yar\u0131m GF, Ba\u015fp\u0131nar N, \u00d6zdemir \u00d6 et al (2021) Protective effects of nobiletin on cisplatin induced neurotoxicity in rats. Int\u00a0J\u00a0Neurosci\u00a01\u20137","DOI":"10.1080\/00207454.2021.1896507"},{"issue":"2","key":"555_CR40","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/01480545.2018.1504058","volume":"42","author":"YA Khadrawy","year":"2019","unstructured":"Khadrawy YA, El-Gizawy MM, Sorour SM, Sawie HG, Hosny EN (2019) Effect of curcumin nanoparticles on the cisplatin-induced neurotoxicity in rat. Drug Chemical Toxicol 42(2):194\u2013202","journal-title":"Drug Chemical Toxicol"},{"key":"555_CR41","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","volume":"268","author":"AR Khan","year":"2017","unstructured":"Khan AR, Liu M, Khan MW, Zhai G (2017) Progress in brain targeting drug delivery system by nasal route. J Control Release 268:364\u2013389. https:\/\/doi.org\/10.1016\/j.jconrel.2017.09.001","journal-title":"J Control Release"},{"issue":"2","key":"555_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4103\/bc.bc_7_19","volume":"5","author":"EA Klomparens","year":"2019","unstructured":"Klomparens EA, Ding Y (2019) The neuroprotective mechanisms and effects of sulforaphane. Brain Circulation 5(2):74","journal-title":"Brain Circulation"},{"issue":"1","key":"555_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"SG K\u00fct\u00fck","year":"2019","unstructured":"K\u00fct\u00fck SG, G\u00f6k\u00e7e G, K\u00fct\u00fck M, Cila HEG, Naz\u0131ro\u011flu M (2019) Curcumin enhances cisplatin-induced human laryngeal squamous cancer cell death through activation of TRPM2 channel and mitochondrial oxidative stress. Sci Rep 9(1):1\u201314","journal-title":"Sci Rep"},{"key":"555_CR44","first-page":"323","volume":"100","author":"MC Lamkowsky","year":"2012","unstructured":"Lamkowsky MC, Geppert M, Schmidt MM, Dringen R (2012) Magnetic Field-Induced Acceleration of the Accumulation of Magnetic Iron Oxide Nanoparticles by Cultured Brain Astrocytes J Biomed Mater Res Part A 100:323\u2013334","journal-title":"Magnetic Field-Induced Acceleration of the Accumulation of Magnetic Iron Oxide Nanoparticles by Cultured Brain Astrocytes J Biomed Mater Res Part A"},{"key":"555_CR45","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/smll.201202111","volume":"9","author":"D Ling","year":"2013","unstructured":"Ling D, Hyeon T (2013) Chemical design of biocompatible iron oxide nanoparticles for medical applications. Small 9:1450\u20131466. https:\/\/doi.org\/10.1002\/smll.201202111","journal-title":"Small"},{"issue":"15","key":"555_CR46","doi-asserted-by":"publisher","first-page":"7808","DOI":"10.1039\/C6NR00147E","volume":"8","author":"H Liu","year":"2016","unstructured":"Liu H, Zhang J, Chen X, Du XS, Zhang JL, Liu G, Zhang WG (2016) Application of iron oxide nanoparticles in glioma imaging and therapy: from bench to bedside. Nanoscale 8(15):7808\u20137826","journal-title":"Nanoscale"},{"issue":"1","key":"555_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2021.103476","volume":"15","author":"N Liu","year":"2022","unstructured":"Liu N, Zhou S, Olatunji OJ, Wu Y (2022) Nucleosides rich extract from Cordyceps cicadae alleviated cisplatin-induced neurotoxicity in rats: a behavioral, biochemical and histopathological study. Arab J Chem 15(1):103476","journal-title":"Arab J Chem"},{"key":"555_CR48","doi-asserted-by":"crossref","unstructured":"Luo S, Ma C, Zhu MQ, Ju WN, Yang Y, Wang X (2020) Application of iron oxide nanoparticles in the diagnosis and treatment of neurodegenerative diseases with emphasis on Alzheimer\u2019s disease.\u00a0Front Cell Neurosci 21\u200f","DOI":"10.3389\/fncel.2020.00021"},{"key":"555_CR49","doi-asserted-by":"crossref","unstructured":"Mabrouk M, Ibrahim Fouad G, El-Sayed SA, Rizk MZ, Beherei HH (2021) Hepatotoxic and neurotoxic potential of iron oxide nanoparticles in wistar rats: a biochemical and ultrastructural study. BTER 1\u201328","DOI":"10.1007\/s12011-021-02943-4"},{"key":"555_CR50","doi-asserted-by":"crossref","unstructured":"Majd NE, Tabandeh MR, Hosseinifar S, Zarneh SR (2021) Chemical and green ZnO nanoparticles ameliorated adverse effects of cisplatin on histological structure, antioxidant defense system and neurotrophins expression in rat hippocampus.\u00a0J Chem Neuroanatomy 101990","DOI":"10.1016\/j.jchemneu.2021.101990"},{"issue":"4","key":"555_CR51","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12640-013-9443-y","volume":"25","author":"S Manohar","year":"2014","unstructured":"Manohar S, Jamesdaniel S, Salvi R (2014) Cisplatin inhibits hippocampal cell proliferation and alters the expression of apoptotic genes. Neurotox Res 25(4):369\u2013380","journal-title":"Neurotox Res"},{"key":"555_CR52","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jddst.2017.09.022","volume":"43","author":"S Md","year":"2018","unstructured":"Md S, Bhattmisra SK, Zeeshan F, Shahzad N et al (2018) Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders. J Drug Deliv Sci Technol 43:295\u2013310","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"555_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146129","volume":"11","author":"MS Medeiros","year":"2016","unstructured":"Medeiros MS, Schumacher-Schuh A, Cardoso AM, Bochi GV, Baldissarelli J et al (2016) Iron and oxidative stress in Parkinson\u2019s disease: an observational study of injury biomarkers. PLoS ONE 11(1):e0146129","journal-title":"PLoS ONE"},{"key":"555_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fnsys.2019.00061","volume":"13","author":"D Milardi","year":"2019","unstructured":"Milardi D, Quartarone A, Bramanti A, Anastasi G et al (2019) The cortico-basal ganglia-cerebellar network: past, present and future perspectives. Front Systems Neurosci 13:61","journal-title":"Front Systems Neurosci"},{"issue":"1","key":"555_CR55","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijpharm.2009.06.019","volume":"379","author":"A Mistry","year":"2009","unstructured":"Mistry A, Stolnik S, Illum L (2009) Nanoparticles for direct nose-to-brain delivery of drugs. Int J Pharm 379(1):146\u2013157","journal-title":"Int J Pharm"},{"key":"555_CR56","first-page":"414","volume":"86","author":"HAC Montgomery","year":"1961","unstructured":"Montgomery HAC, Dymock JF (1961) The determination of nitrate in water. Analyst 86:414\u2013416","journal-title":"Analyst"},{"key":"555_CR57","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.bbr.2019.02.031","volume":"364","author":"A Nadeem","year":"2019","unstructured":"Nadeem A, Ahmad SF, Al-Harbi NO, Attia SM, Bakheet SA et al (2019) Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+ tf\/J mice. Behav Brain Res 364:213\u2013224","journal-title":"Behav Brain Res"},{"key":"555_CR58","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0304-3959(77)90135-X","volume":"4","author":"R Necker","year":"1977","unstructured":"Necker R, Hellon RF (1977) Noxious thermal input from the rat tail: modulation by descending inhibitory influences. Pain 4:231\u2013242","journal-title":"Pain"},{"issue":"2","key":"555_CR59","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","volume":"95","author":"H Ohkawa","year":"1979","unstructured":"Ohkawa H et al (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95(2):351\u2013358","journal-title":"Anal Biochem"},{"key":"555_CR60","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.biopha.2018.03.051","volume":"102","author":"O Owoeye","year":"2018","unstructured":"Owoeye O, Adedara IA, Farombi EO (2018) Pretreatment with taurine prevented brain injury and exploratory behaviour associated with administration of anticancer drug cisplatin in rats. Biomed Pharmacoth 102:375\u2013384","journal-title":"Biomed Pharmacoth"},{"issue":"9","key":"555_CR61","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.ki.5002786","volume":"73","author":"N Pabla","year":"2008","unstructured":"Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney INT 73(9):994\u20131007","journal-title":"Kidney INT"},{"issue":"1","key":"555_CR62","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/nano11010002","volume":"11","author":"E Panzarini","year":"2020","unstructured":"Panzarini E, Mariano S, Tacconi S, Carata E, Tata AM, Dini L (2020) Novel therapeutic delivery of nanocurcumin in central nervous system related disorders. Nanomaterials 11(1):2","journal-title":"Nanomaterials"},{"issue":"2","key":"555_CR63","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.nano.2011.05.016","volume":"8","author":"S Parveen","year":"2012","unstructured":"Parveen S, Misra R, Sahoo SK (2012) Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanotechnol Biol Med 8(2):147\u2013166","journal-title":"Nanotechnol Biol Med"},{"issue":"6","key":"555_CR64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001462","volume":"10","author":"I Pichler","year":"2013","unstructured":"Pichler I, Del Greco MF, G\u00f6gele M, Lill CM, Bertram L et al (2013) Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study. PLoS Med 10(6):e1001462","journal-title":"PLoS Med"},{"key":"555_CR65","doi-asserted-by":"crossref","unstructured":"Pires A, Fortuna A, Alves G, Falc\u00e3o A (2009) Intranasal drug delivery: how, why and what for. J\u00a0Pharm\u00a0Pharm\u00a0Sci 12(3):288\u2013311","DOI":"10.18433\/J3NC79"},{"key":"555_CR66","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jconrel.2017.11.047","volume":"270","author":"PC Pires","year":"2018","unstructured":"Pires PC, Santos AO (2018) Nanosystems in nose-to-brain drug delivery: a review of non-clinical brain targeting studies. J Control Release 270:89\u2013100","journal-title":"J Control Release"},{"issue":"3","key":"555_CR67","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.neuroscience.2004.08.023","volume":"129","author":"MB Pisu","year":"2004","unstructured":"Pisu MB, Roda E, Avella D, Bernocchi G (2004) Developmental plasticity of rat cerebellar cortex after cisplatin injury: inhibitory synapses and differentiating Purkinje neurons. Neurosc 129(3):655\u2013664","journal-title":"Neurosc"},{"key":"555_CR68","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s0165-0173(98)00016-2","volume":"28","author":"A Reiner","year":"1998","unstructured":"Reiner A, Medina L, Veenman CL (1998) Structural and functional evolution of the basal ganglia in vertebrates. Brain Res Rev 28:235\u2013285. https:\/\/doi.org\/10.1016\/s0165-0173(98)00016-2","journal-title":"Brain Res Rev"},{"key":"555_CR69","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.phrs.2017.01.001","volume":"117","author":"X Ren","year":"2017","unstructured":"Ren X, Clair DKS, Butterfield DA (2017) Dysregulation of cytokine mediated chemotherapy induced cognitive impairment. Pharmacol Res 117:267\u2013273","journal-title":"Pharmacol Res"},{"key":"555_CR70","doi-asserted-by":"publisher","unstructured":"Rosen JE, Chan L, Shieh DB, Gu FX (2012) Iron oxide nanoparticles for targeted cancer imaging and diagnostics.\u00a0Nanomed Nanotechnol Biol Med 8(3):275\u2013290. https:\/\/doi.org\/10.1016\/j.nano.2011.08.017","DOI":"10.1016\/j.nano.2011.08.017"},{"issue":"3","key":"555_CR71","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1007\/s12640-020-00315-9","volume":"39","author":"H Saadati","year":"2021","unstructured":"Saadati H, Noroozzadeh S, Esmaeili H, Amirshahrokhi K, Shadman J, Niapour A (2021) The neuroprotective effect of Mesna on cisplatin-induced neurotoxicity: behavioral, electrophysiological, and molecular studies. Neurotox Res 39(3):826\u2013840","journal-title":"Neurotox Res"},{"key":"555_CR72","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ejphar.2019.04.043","volume":"855","author":"DO Saleh","year":"2019","unstructured":"Saleh DO, Mansour DF, Hashad IM, Bakeer RM (2019) Effects of sulforaphane on D-galactose-induced liver aging in rats: role of keap-1\/nrf-2 pathway. Eur J Pharmacol 855:40\u201349","journal-title":"Eur J Pharmacol"},{"issue":"10","key":"555_CR73","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1080\/1061186X.2019.1608553","volume":"27","author":"HF Salem","year":"2019","unstructured":"Salem HF, Kharshoum RM, Abou-Taleb HA et al (2019) Brain targeting of resveratrol through intranasal lipid vesicles labelled with gold nanoparticles: in vivo evaluation and bioaccumulation investigation using computed tomography and histopathological examination. J Drug Target 27(10):1127\u20131134","journal-title":"J Drug Target"},{"issue":"8","key":"555_CR74","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/00207454.2012.673515","volume":"122","author":"M Shabani","year":"2012","unstructured":"Shabani M, Larizadeh MH, Parsania S, Hajali V, Shojaei A (2012a) Evaluation of destructive effects of exposure to cisplatin during developmental stage: no profound evidence for sex differences in impaired motor and memory performance. Int J Neurosci 122(8):439\u2013448","journal-title":"Int J Neurosci"},{"issue":"5","key":"555_CR75","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.neuro.2012.08.004","volume":"33","author":"M Shabani","year":"2012","unstructured":"Shabani M, Nazeri M, Parsania S, Razavinasab M et al (2012b) Walnut consumption protects rats against cisplatin-induced neurotoxicity. Neurotox 33(5):1314\u20131321","journal-title":"Neurotox"},{"issue":"4","key":"555_CR76","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.etp.2015.02.003","volume":"67","author":"N Sharawy","year":"2015","unstructured":"Sharawy N, Rashed L, Youakim MF (2015) Evaluation of multi-neuroprotective effects of erythropoietin using cisplatin induced peripheral neurotoxicity model. Experim Toxicol Path 67(4):315\u2013322","journal-title":"Experim Toxicol Path"},{"key":"555_CR77","doi-asserted-by":"crossref","unstructured":"Siegal T, Haim N (1990) Cisplatin\u2010induced peripheral neuropathy. Frequent off\u2010therapy deterioration, demyelinating syndromes, and muscle cramps.\u00a0Cancer 66(6):1117\u20131123","DOI":"10.1002\/1097-0142(19900915)66:6<1117::AID-CNCR2820660607>3.0.CO;2-O"},{"issue":"2","key":"555_CR78","first-page":"208","volume":"8","author":"K Singh","year":"2016","unstructured":"Singh K, Ahmad Z, Shakya P, Ansari VA, Kumar A, Zishan M, Arif M (2016) Nano formulation: a novel approach for nose to brain drug delivery. J Chem Pharm Res 8(2):208\u2013215","journal-title":"J Chem Pharm Res"},{"issue":"8","key":"555_CR79","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.tiv.2011.06.012","volume":"25","author":"L Sun","year":"2011","unstructured":"Sun L, Li Y, Liu X, Jin M et al (2011) Cytotoxicity and mitochondrial damage caused by silica nanoparticles. Toxicol in Vitro 25(8):1619\u20131629","journal-title":"Toxicol in Vitro"},{"key":"555_CR80","volume-title":"Bancroft\u2019s theory and practice of histological techniques","author":"SK Suvarna","year":"2019","unstructured":"Suvarna SK, Layton C, Bancroft JD (2019) Bancroft\u2019s theory and practice of histological techniques. Churchill Livingstone Elsevier, Oxford"},{"issue":"11","key":"555_CR81","first-page":"1199","volume":"93","author":"N Van Wijk","year":"2008","unstructured":"Van Wijk N, Rijntjes E, Van De Heijning BJM (2008) Perinatal and chronic hypothyroidism impair behavioural development in male and female rats. Experim Phys 93(11):1199\u20131209","journal-title":"Experim Phys"},{"issue":"1","key":"555_CR82","first-page":"1","volume":"10","author":"MC Veronesi","year":"2020","unstructured":"Veronesi MC, Alhamami M, Miedema SB, Yun Y, Ruiz-Cardozo M, Vannier MW (2020) Imaging of intranasal drug delivery to the brain. Am J Nucl Med 10(1):1","journal-title":"Am J Nucl Med"},{"issue":"6","key":"555_CR83","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/bcpt.13643","volume":"129","author":"SA Wahdan","year":"2021","unstructured":"Wahdan SA, Elsherbiny DA, Azab SS, El-Demerdash E (2021) Piceatannol ameliorates behavioural, biochemical and histological aspects in cisplatin-induced peripheral neuropathy in rats. Basic Clin Pharmacol Toxicol 129(6):486\u2013495","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"555_CR84","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3233\/JAD-2012-111169","volume":"30","author":"L Wan","year":"2012","unstructured":"Wan L, Nie G, Zhang J, Zhao B (2012) Overexpression of human wild-type amyloid-beta protein precursor decreases the iron content and increases the oxidative stress of neuroblastoma SH-SY5Y cells. J Alzheimers Dis 30:523\u2013530","journal-title":"J Alzheimers Dis"},{"issue":"12","key":"555_CR85","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1002\/ijc.30252","volume":"139","author":"HR Wardill","year":"2016","unstructured":"Wardill HR, Mander KA, Van Sebille YZ, Gibson RJ, Logan RM, Bowen JM, Sonis ST (2016) Cytokine-mediated blood brain barrier disruption as a conduit for cancer\/chemotherapy-associated neurotoxicity and cognitive dysfunction. Int J Cancer 139(12):2635\u20132645","journal-title":"Int J Cancer"},{"key":"555_CR86","doi-asserted-by":"crossref","unstructured":"Wichmann T, DeLong MR (2008) Systems level physiology of the basal ganglia, and pathophysiology of Parkinson\u2019s disease. In:\u00a0Parkinson\u2019s Disease. Academic Press, pp 55\u201363\u200f","DOI":"10.1016\/B978-0-12-374028-1.00005-1"},{"key":"555_CR87","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.neuro.2012.09.006","volume":"34","author":"J Wu","year":"2013","unstructured":"Wu J, Ding T, Sun J (2013) Neurotoxic potential of iron oxide nanoparticles in the rat brain striatum and hippocampus. Neurotoxicol 34:243\u2013253","journal-title":"Neurotoxicol"},{"issue":"8","key":"555_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e02247","volume":"5","author":"YC Yadav","year":"2019","unstructured":"Yadav YC (2019) Effect of cisplatin on pancreas and testes in Wistar rats: biochemical parameters and histology. Heliyon 5(8):e02247","journal-title":"Heliyon"},{"key":"555_CR89","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12868-017-0369-9","volume":"18","author":"Z Yarjanli","year":"2017","unstructured":"Yarjanli Z, Ghaedi K, Esmaeili A, Rahgozar S, Zarrabi A (2017) Iron oxide nanoparticles may damage to the neural tissue through iron accumulation, oxidative stress and protein aggregation. BMC Neurosci 18:51. https:\/\/doi.org\/10.1186\/s12868-017-0369-9","journal-title":"BMC Neurosci"},{"issue":"2","key":"555_CR90","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000103641","volume":"58","author":"S Younes-Mhenni","year":"2007","unstructured":"Younes-Mhenni S, Frih-Ayed M, Kerkeni A, Bost M, Chazot G (2007) Peripheral blood markers of oxidative stress in Parkinson\u2019s disease. Eur Neurol 58(2):78\u201383","journal-title":"Eur Neurol"},{"key":"555_CR91","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1186\/1744-8069-8-55","volume":"8","author":"M Zhao","year":"2012","unstructured":"Zhao M, Isami K, Nakamura S, Shirakawa H, Nakagawa T, Kaneko S (2012) Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice. Mol Pain 8:1744\u20138069","journal-title":"Mol Pain"},{"issue":"3","key":"555_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151890","volume":"11","author":"W Zhou","year":"2016","unstructured":"Zhou W, Kavelaars A, Heijnen CJ (2016) Metformin prevents cisplatin-induced cognitive impairment and brain damage in mice. PLoS ONE 11(3):e0151890","journal-title":"PLoS ONE"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-022-00555-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-022-00555-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-022-00555-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T22:12:48Z","timestamp":1676412768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-022-00555-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["555"],"URL":"https:\/\/doi.org\/10.1007\/s12640-022-00555-x","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"assertion":[{"value":"27 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of National Research Centre (NRC), Egypt (approval no. 19\u2013313).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}